DRMA ▲ +36.4% - Dermata Therapeutics, Inc. $DRMA DRMAW - Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment 15-OCT-2026 08:05 AM ET